Francesca Magri

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

Eugenio Mercuri, Francesco Muntoni, Giovanni Baranello et al. · The Lancet Neurology · 2021 · 237 citations

Gene Therapies, Clinical Trials, Neurology +2

Reliability of the North Star Ambulatory Assessment in a multicentric setting

Elena Mazzone, Sonia Messina, Gessica Vasco et al. · Neuromuscular Disorders · 2009 · 221 citations

Reliability, Quality Of Life, Reliability Analysis +9

Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients

Michela Guglieri, Francesca Magri, Maria Grazia D’Angelo et al. · Human Mutation · 2007 · 208 citations

Genetics, Genetic Epidemiology, Pathology +18

Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy

Stefania Corti, Monica Nizzardo, Chiara Simone et al. · Science Translational Medicine · 2012 · 204 citations · Full text

Histological effects of givinostat in boys with Duchenne muscular dystrophy

P. Bettica, Stefania Petrini, Valentina Doria et al. · Neuromuscular Disorders · 2016 · 191 citations · Full text